Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib

por Emole J, Talabi T, Pinilla-Ibarz J
Publicado 2016

Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study

por Terry C. Davis, Connie L. Arnold, Glenn Mills, Glenn J. Lesser, W. Mark Brown, Richard Schulz, Kathryn E. Weaver, Pamala A. Pawloski
Publicado 2021

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous le...

por Haidée Aranda-Tavío, Carlota Recio, Pedro Martín-Acosta, Miguel Guerra-Rodríguez, Yeray Brito-Casillas, Rosa Blanco, Vanessa Junco, Javier León, Juan Carlos Montero, Lucía Gandullo-Sánchez, Grant McNaughton-Smith, Juan Manuel Zapata, Atanasio Pandiella, Angel Amesty, Ana Estévez-Braun, Leandro Fernández-Pérez, Borja Guerra
Publicado 2021

Novel Treatment Strategies Utilizing Immune Reactions against Chronic Myelogenous Leukemia Stem Cells

por Maiko Matsushita
Publicado 2021

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches

por Panagiotis T. Diamantopoulos, Nora-Athina Viniou
Publicado 2021